Starling Oncology, Inc. (STLN) stock
STLNNasdaqServices-Offices & Clinics of Doctors of MedicineFiscal year ends December 31Also trades as DFPH, STLNW
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Nov 6, 2026Score 7/30
$3.20−0.20 (-5.88%)
Close on Nov 18, 2026Market cap $326.13MP/E –Yield –
Starling Oncology price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
Starling Oncology's price to book ratio was 64.4× on Jul 31, 2025, against 1.0× a year earlier. Over the last 5 years it ranged from 0.3× to 64.4×, with a median of 2.7×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2025 | Jul 31, 2025 | 64.4× | +62.9 |
| 2024 | Dec 31, 2024 | 1.5× | −0.6 |
| 2023 | Dec 29, 2023 | 2.1× | +1.2 |
| 2022 | Dec 30, 2022 | 0.9× | −3.8 |
| 2021 | Dec 31, 2021 | 4.7× | – |
See a number that looks wrong?